Tech Center 3700 • Art Units: 1631 1671 1687 3781
This examiner grants 64% of resolved cases
Lori A Clow is an examiner in Tech Center 3700 and Art Unit 1631. She has 715 resolved cases and an allowance rate of 64.2 percent. This rate suggests the probability of success for applicants. The median days to allowance is 1544, which indicates the timeline for the prosecution process.
The interview lift is 28.5 percent. This lift shows that interviews are a tool for increasing the 64.2 percent allowance rate. In Tech Center 3700, the 28.5 percent lift can be used for overcoming rejections and moving toward an allowance.
With 715 resolved cases, the examiner's statistics are supported by the data. The 64.2 percent allowance rate and the 1544 days median to allowance are factors for practitioners in Art Unit 1631. Utilizing the 28.5 percent interview lift may help address the duration of the prosecution. The combination of these metrics defines the current prosecution landscape for this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17761628 | METHODS AND SYSTEMS FOR MODELING A CARDIAC SYSTEM | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18124670 | MITOCHONDRIAL PROBES FOR ENDOGENOUS CONTROL AND CONTAMINATION DETECTION | Non-Final OA | Helix, Inc. |
| 17406948 | IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACID TUMOR MARKERS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17817631 | BIOLOGICAL SEQUENCE DISTANCE EXPLORER SYSTEM PROVIDING USER VISUALIZATION OF GENOMIC DISTANCE BETWEEN A SET OF GENOMES IN A DYNAMIC ZOOMABLE FASHION | Final Rejection | International Business Machines Corporation |
| 17821916 | UTILIZING DEEP REINFORCEMENT LEARNING FOR DISCOVERING NEW COMPOUNDS | Non-Final OA | Accenture Global Solutions Limited |
| 18192330 | FORECASTING MACROPHAGE ACTIVATION SYNDROMES | Non-Final OA | CERNER INNOVATION, INC. |
| 17636079 | OPTICAL BASED METHODS FOR DETERMINING ANTIMICROBIAL DOSING REGIMENS | Non-Final OA | University of Houston System |
| 18342178 | METHODS AND SYSTEMS FOR PREDICTING SENSITIVITY OF BLOOD FLOW CALCULATIONS TO CHANGES IN ANATOMICAL GEOMETRY | Non-Final OA | HeartFlow, Inc. |
| 18325341 | SYSTEMS AND METHODS FOR PROCESSING ELECTRONIC IMAGES TO PREDICT LESIONS | Non-Final OA | HeartFlow, Inc. |
| 18322214 | SYSTEMS AND METHODS FOR PROCESSING ELECTRONIC IMAGES TO PREDICT LESIONS | Non-Final OA | HeartFlow, Inc. |
| 18168870 | SYSTEMS AND METHODS FOR PATIENT IMAGE PROCESSING TO EVALUATE TISSUE FUNCTION | Non-Final OA | HeartFlow, Inc. |
| 17810735 | SYSTEMS AND METHODS FOR PROCESSING ELECTRONIC IMAGES TO MODEL NUTRIENT TRANSPORT | Non-Final OA | HeartFlow, Inc. |
| 17655746 | SYSTEMS AND METHODS FOR PROCESSING IMAGES TO DETERMINE PLAQUE PROGRESSION AND REGRESSION | Final Rejection | HeartFlow, Inc. |
| 18243594 | COMPUTE SCHEDULING FOR SEQUENCING ANALYSIS | Non-Final OA | ILLUMINA, INC. |
| 17425384 | NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER | Non-Final OA | UEA ENTERPRISES LIMITED |
| 17691999 | METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID | Final Rejection | SEQUENOM, INC. |
| 17855010 | METHOD AND SYSTEM FOR CONVERTING PHYSIOLOGICAL SIGNALS | Non-Final OA | Terra Quantum AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy